中文 | English
Return
Total: 2391 , 1/240
Show Home Prev Next End page: GO
Author:(Dong-Xu ZHANG)

1.New onset or exacerbation of psoriatic skin lesions in patients with arthritides treated with tumor necrosis factor alpha antagonists

Xiaomei LENG ; Dong XU ; Fengchun ZHANG

Chinese Journal of Rheumatology 2008;12(10):694-696

2.Effect of ketamine on the expression of HSP 70 in myocardium in severely burned rats

Ling DONG ; Yanbing XU ; Mengyuan ZHANG

Chinese Journal of Anesthesiology 2008;28(9):797-799

3.Study of the relations between primary biliary cirrhosis and anti-gp210 and anti-sp100 antibody

Dong XU ; Fengchun ZHANG ; Wei LIU

Chinese Journal of Rheumatology 2008;12(8):540-542

5.Locking compression plate fixation for the acetabular fractures

Yu ZHANG ; Nanwei XU ; Dong ZHOU

Orthopedic Journal of China 2006;0(06):-

6.Study on Components of Effective Parts Ⅰ in Zhou's Prescription of Anti-Human Lung Cancer on A549 Cells

Jing DONG ; Lian YIN ; Xu ZHANG

Chinese Journal of Information on Traditional Chinese Medicine 2006;0(11):-

7.Clinical analysis of 10 cases of connective tissue diseases with lung bullae

Dong XU ; Fengchun ZHANG ; Jingyun LI

Chinese Journal of Rheumatology 2003;0(11):-

8.Extracorporeal Liver Support with Less Fresh Frozen Plasma for Treatment of Acute-on-chronic Liver Failure

Lisha ZHANG ; Manzhi ZHAO ; Dong XU

Acta Medicinae Universitatis Scientiae et Technologiae Huazhong 2015;(1):87-91

9.Therapeutic effect of photodynamic therapy and intravitreal injection with ranibizumab for choroidal neovascularization of pathologic myopia

Cong, ZHANG ; Dong-Ning, LIU ; Li, XU

International Eye Science 2014;(7):1212-1215

10.Analysis on the changes of routine blood tests results after therapy of chlorpromazine, clozapine or perphenazine changed to risperidone in schizophrenic patients

Fangqing DONG ; Xiaoguang ZHANG ; Huakun XU

International Journal of Laboratory Medicine 2015;(20):2961-2962

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2391 , 1/240 Show Home Prev Next End page: GO